BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32727778)

  • 1. Clinical Implications of Cancer Stem Cell Markers and ABC Transporters as a Predictor of Prognosis in Colorectal Cancer Patients.
    Kim BH; Oh HK; Kim DW; Kang SB; Choi Y; Shin E
    Anticancer Res; 2020 Aug; 40(8):4481-4489. PubMed ID: 32727778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implication of ABC transporters and cancer stem cell markers in patients with stage III colon cancer receiving adjuvant FOLFOX-4 chemotherapy.
    Han SH; Kim JW; Kim M; Kim JH; Lee KW; Kim BH; Oh HK; Kim DW; Kang SB; Kim H; Shin E
    Oncol Lett; 2019 Jun; 17(6):5572-5580. PubMed ID: 31186779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
    Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
    Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
    Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
    BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Cancer Stem Cell Markers in Cervical Cancer: A Systematic Review and Meta-Analysis.
    Fahmi MN; Hertapanndika IN; Kusuma F
    Asian Pac J Cancer Prev; 2021 Dec; 22(12):4057-4065. PubMed ID: 34967589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
    You L; Guo X; Huang Y
    Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
    Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
    Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
    Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
    PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
    Hou T; Zhang W; Tong C; Kazobinka G; Huang X; Huang Y; Zhang Y
    BMC Cancer; 2015 Oct; 15():785. PubMed ID: 26499463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
    Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
    Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.
    Kim ST; Sohn I; DO IG; Jang J; Kim SH; Jung IH; Park JO; Park YS; Talasaz A; Lee J; Kim HC
    Cancer Genomics Proteomics; 2014; 11(5):259-66. PubMed ID: 25331798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
    Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
    Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers.
    Salehzadeh S; Hasanzad M; Kadijani AA; Akbari A
    J Gastrointest Cancer; 2020 Jun; 51(2):591-599. PubMed ID: 31422541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
    Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.